Cargando…
In-depth proteomic analysis of tissue interstitial fluid for hepatocellular carcinoma serum biomarker discovery
BACKGROUND: Hepatocellular carcinoma (HCC) is a primary malignancy of the liver. New serum biomarkers for HCC screening are needed, especially for alpha-fetoprotein (AFP) negative patients. As a proximal fluid between body fluids and intracellular fluid, tissue interstitial fluid (TIF) is a suitable...
Autores principales: | Zhang, Jian, Hao, Ning, Liu, Wei, Lu, Min, Sun, Longqin, Chen, Ning, Wu, Miantao, Zhao, Xiaohang, Xing, Baocai, Sun, Wei, He, Fuchu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729441/ https://www.ncbi.nlm.nih.gov/pubmed/29024941 http://dx.doi.org/10.1038/bjc.2017.344 |
Ejemplares similares
-
Quantitative Proteomics Analysis of Tissue Interstitial Fluid for Identification of Novel Serum Candidate Diagnostic Marker for Hepatocellular Carcinoma
por: Sun, Wei, et al.
Publicado: (2016) -
Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis
por: Xue, A, et al.
Publicado: (2010) -
Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis
por: Ward, D G, et al.
Publicado: (2006) -
In-Depth Serum Proteomics Reveals the Trajectory of Hallmarks of Cancer in Hepatitis B Virus–Related Liver Diseases
por: Xu, Meng, et al.
Publicado: (2023) -
Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma
por: Shimwell, N J, et al.
Publicado: (2013)